Global Gene Expression Analysis Market, By Product (Instruments, Reagents and Consumables and Services), Technology (Polymerase Chain Reaction, Next-Generation Sequencing, DNA Microarray, Serial Analysis of Gene Expression and Northern Blotting), Application (Drug Discovery, Research and Diagnostics), End User (Pharmaceutical and Biotechnology Companies, Academic Institutes and Research Centres, Diagnostic Laboratories and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Rising prevalence of cancer patients globally in turn has led to the rise in demand and application of gene expression analysis. Data Bridge Market Research analyses that the gene expression analysis will exhibit a CAGR of around 8.36% for the forecast period of 2021-2028.
Gene expression is a process wherein the instructions in DNA are converted into a functional product such as protein. In other words, this method involves the extraction of data from a gene and uses it for the production of a practical gene product. This is a delicate biological activity where a single change in the gene expression pattern would lead to a change in the whole biological process.
The rising prevalence of genomics along with the availability of gene expression databases has led to the rise in gene expression analysis market value. Rising cases of cancer have further boosted the demand for gene expression analysis. Increased research and development activities for advanced healthcare frameworks coupled with the adoption of advanced technology in drug diagnostics and drug development have led to the rise in demand for gene expression analysis. Increased government funding in the direction of genomics has further propelled the market growth rate.
However, the high cost of equipment will derail the gene expression analysis market growth rate. Also, the dearth of skilled expertise or trained personnel will hammer down the market growth rate. Lack of awareness about gene expression analysis coupled with the low level of the technological base in underdeveloped countries will further slowdown the market growth rate.
This gene expression analysis market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on gene expression analysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Gene Expression Analysis Market Scope and Market Size
The gene expression analysis market is segmented on the basis of product, technology, application and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on the product, the gene expression analysis market has been segmented into instruments, reagents and consumables and services. Reagents and consumables are further sub-segmented into reagents and DNA chips. Services are further sub-segmented into gene expression profiling services, sequencing services and bioinformatics solutions.
- Based on the technology, the gene expression analysis market has been segmented into polymerase chain reaction, next-generation sequencing, DNA microarray, serial analysis of gene expression and northern blotting.
- Based on the application, the gene expression analysis market has been segmented into drug discovery, research and diagnostics.
- Based on the end users, the gene expression analysis market has been segmented into pharmaceutical and biotechnology companies, academic institutes and research centres, diagnostic laboratories and others.
Gene Expression Analysis Market Country Level Analysis
The gene expression analysis market is analysed and market size insights and trends are provided by country, product, technology, application and end users as referenced above.
The countries covered in the gene expression analysis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the gene expression analysis market and will continue to during the forecast period. This is due to various reasons such as prevalence of a good healthcare infrastructure, supportive governmental policies and provisions for drug discovery activities, increased expenditure on technological advancements and increased investment in genomics. However, it is Asia-Pacific region which is set to undergo the highest growth rate during the forecast period. This is because of introduction of various policies to induce foreign investment into the developing regions coupled with increased interest of major key players to enter into the untapped markets.
The country section of the gene expression analysis market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed Base and New Technology Penetration
Gene expression analysis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for gene expression analysis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the gene expression analysis market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Gene Expression Analysis Market Share Analysis
The gene expression analysis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to gene expression analysis market.
The major players covered in the gene expression analysis market report are QIAGEN, Quest Diagnostics Incorporated., F. Hoffmann-La Roche Ltd, Illumina, Inc., Novogene Co., Ltd., PerkinElmer Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., GENERAL ELECTRIC COMPANY, Promega Corporation., Luminex Corporation., Takara Bio Inc., Danaher., Merck Sharp & Dohme Corp., Genotypic Technology Pvt Ltd, Macrogen, Inc., Eurofins Scientific., Novogene Co., Ltd., SciGenom Labs Pvt. Ltd and TAKARA HOLDINGS INC. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.